OpenVSafe by OpenVAERS
Search V-safe

5YE-12057-90950

4 vaccinations 20 coded responses 28 check-ins 20 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
191 / PA
Registered
2021-03-21
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-21
    Registered in v-safe
  2. 2021-03-21
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-21
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  4. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-03-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Acne, Dysgeusia, Hypoaesthesia — Feeling: Fair · Site: Redness, Itching · Headache, Joint pains, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Acne, metallic taste in the mouth, and numbness in the head
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dysgeusia — Feeling: Fair · Site: Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Metallic taste in the mouth
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Acne — Feeling: Fair · Site: Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Acne
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-28
    Survey response — day 7, dose 1
    MedDRA: Acne — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Acne is growing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-04
    Survey response — day 14, dose 1
    MedDRA: Dyspnoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Difficulty of breathing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-09
    Dose 2 — Pfizer-BioNTech
  11. 2021-04-09
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  12. 2021-04-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-04-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Taste disorder — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Change in taste
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Taste disorder — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Change in taste
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Taste disorder — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Change of taste
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Taste disorder — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Change in taste
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Taste disorder — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Change in taste
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-16
    Survey response — day 7, dose 2
    MedDRA: Taste disorder — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Change in taste
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-23
    Survey response — day 14, dose 2
    MedDRA: Fatigue, Nasopharyngitis, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Head cold, fever, fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-30
    Survey response — day 21, dose 2
    MedDRA: Nasopharyngitis, Pyrexia, Rash, SARS-CoV-2 test — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Rashes all over the body, head cold, and fever · Healthcare visit (other): Test for Covid-19
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-30
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-05-07
    Survey response — day 28, dose 2
    MedDRA: Swelling — Feeling: Fair
    Free text: Red bumps
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-16
    Survey response — day 35, dose 2
    MedDRA: Rash, Rash erythematous, Taste disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Change in taste and red bumps all over the body
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-05-21
    Survey response — day 42, dose 2
    MedDRA: Nasopharyngitis, Pyrexia, Rash, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Fever, cold, rash. · Healthcare visit (other): Testing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-21
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-07-09
    Survey response — 3 months, dose 2
    MedDRA: Acne, Rash erythematous — Feeling: Good
    Free text: Red bumps/acne on the body
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-10-09
    Survey response — 6 months, dose 2
    MedDRA: Fatigue, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Constant cold and fatigue
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-11-06
    Dose 3 — Pfizer-BioNTech
  29. 2022-04-09
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-04-15
  31. 2022-06-10
    Dose 4 — Moderna
  32. 2022-06-21
    Survey response — day 7, dose 4
    MedDRA: Confusional state, Dysgraphia, Emotional disorder, Speech disorder — Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Confusion in writing/typing, talking, understanding, emotional regulation
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-06-28
    Health check-in — day 14, dose 4
    Feeling: Fair
    Adult check-in
  34. 2022-07-11
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-07-17
    Survey response — day 35, dose 4
    MedDRA: Dyspnoea — Feeling: Fair
    Free text: Shortness of breath
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-12-09
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-21Pfizer-BioNTech
22021-04-09Pfizer-BioNTech
32021-11-06Pfizer-BioNTech No
42022-06-10Moderna No

Call center

2 call center cases

2 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-24

Systemic reaction (other): Acne, metallic taste in the mouth, and numbness in the head

2021-03-25

Systemic reaction (other): Metallic taste in the mouth

2021-03-26

Systemic reaction (other): Acne

Release 6 — day 7, dose 1

2021-03-28

Systemic reaction (other): Acne is growing

Release 6 — day 14, dose 1

2021-04-04

Symptoms: Difficulty of breathing

Release 7 — days 1–6 daily, dose 2

2021-04-11

Systemic reaction (other): Change in taste

2021-04-12

Systemic reaction (other): Change in taste

2021-04-13

Systemic reaction (other): Change of taste

2021-04-14

Systemic reaction (other): Change in taste

2021-04-15

Systemic reaction (other): Change in taste

Release 7 — day 7, dose 2

2021-04-16

Systemic reaction (other): Change in taste

Release 7 — day 14, dose 2

2021-04-23

Symptoms: Head cold, fever, fatigue

Release 8 — day 21, dose 2

2021-04-30

Symptoms: Rashes all over the body, head cold, and fever
Healthcare visit (other): Test for Covid-19

Release 8 — day 28, dose 2

2021-05-07

Symptoms: Red bumps

Release 8 — day 35, dose 2

2021-05-16

Symptoms: Change in taste and red bumps all over the body

Release 8 — day 42, dose 2

2021-05-21

Symptoms: Fever, cold, rash.
Healthcare visit (other): Testing

Release 9 — 3 months, dose 2

2021-07-09

Symptoms: Red bumps/acne on the body

Release 10 — 6 months, dose 2

2021-10-09

Symptoms: Constant cold and fatigue

Release 12 — day 7, dose 4

2022-06-21

Systemic reaction (other): Confusion in writing/typing, talking, understanding, emotional regulation

Release 12 — day 35, dose 4

2022-07-17

Symptoms: Shortness of breath

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSARS-CoV-2 test ✓ ✓ ✓
HCVOUnevaluable event ✓ ✓ ✓
SDAcne ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDNasopharyngitis ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDRash erythematous ✓ ✓ ✓
SDSwelling ✓ ✓ ✓
SDTaste disorder ✓ ✓ ✓
SROAcne ✓ ✓ ✓
SROConfusional state · · ✓
SRODysgeusia ✓ ✓ ✓
SRODysgraphia · · ✓
SROEmotional disorder · · ✓
SROHypoaesthesia ✓ ✓ ✓
SROSpeech disorder · · ✓
SROTaste disorder ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release